TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.
D000818:Animals; D001921:Brain / Q000276:immunology* / Q000503:physiopathology; D004660:Encephalitis / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology; D019636:Neurodegenerative Diseases / Q000276:immunology* / Q000503:physiopathology; D055495:Neurogenesis / Q000276:immunology; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000276:immunology*; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha